"Strofantin" ọgwụ ọjọọ. Ntuziaka maka ojiji

Drug "Strofantin" na-ezo aka a otu nke gbasara obi glycosides. Ọ na-atụ aro ya n'ihi na obi ọdịda ọzọ karịa nnukwu ma ọ bụ ala ala ụdị, dị ka nke ọma dị ka paroxysmal tachycardia.

The agwọ ọrịa "Strofantin" onye udi ndebanye - a akpali mmasị solution, nke ha physico-chemical Njirimara bụ a uzo mmiri mmiri nke na-enweghị agba. Isi nọ n'ọrụ mgwa nke ọgwụ bụ ngwakọta nke gbasara obi glycosides ewepụtara ọgwụ osisi strophanthus mkpụrụ.

The agwọ ọrịa "Strofantin", ntuziaka maka ojiji nke na-ewebata ya edinam arụpụta cardiotonic mmetụta, na-amụba ọsọ na ike nke mkpi nke obi uru. The glycosides nke bụ a akụkụ nke ọgwụ, na-akwalite ubara ọbara olu ejected maka myocardial mkpi na otu maka a nkeji. Na obi odida agwọ ọrịa enhances ventricular nsị. Nke a na-ebelata ihe infarction size, nke na-ebelata ya oxygen ina. The ọgwụgwọ mmetụta nke ọgwụ na-adị n'ime atọ na iri nkeji mgbe ọ bụ ndenye na dịruru otu ụbọchị atọ.

Drug "Strofantin" ntụziaka ntuziaka na-akọwa ya na mmetụta na-ahụ, nwere niile isi pharmacological Njirimara nwere ndị gbasara obi glycosides, ma, n'adịghị ha, cardiotonic edinam nke ọgwụ ike na ọ na-egosi ezi ọsọ ọsọ. Ọgwụ nwere obere utịp ke myocardium n'afọ iri na ụma na-adịghị egbochi ndị conduction nke gboo na ngugu alaka ngọngọ. Nkwadebe "Strofantin" ntụziaka nke na-akọwa a usoro ojiji, na-ndinọ intravenously na obere doses. N'ihi na nke akwusighi nke ya, o gosiworo obere ọgwụgwọ mmetụta mgbe ndinọ. The ọgwụ adịghị akpọkọtara ke idem, Otú ọ dị, nwere ike ime ka a na-egbu egbu mmeghachi omume na mmekọrịta digitalis ọgwụ. Iji zere nke a pụrụ isi kwuo ya, ọ na-agbara intravenously nanị mgbe digitalis ọgwụgwọ ụlọ ọrụ. The ezumike ga-abụ site anọ na ụbọchị isii. Almost iri anọ percent nke ndinọ ọgwụ ejikọ na-edozi hụrụ ọbara plasma. Isi nọ n'ọrụ bekee anyụpụ site na akụrụ na-agbanweghi agbanwe.

The agwọ ọrịa "Strofantin" (ntụziaka ntuziaka na-akọwa isi daa ọrịa nke ọ na-atụ aro iji) na-owụt ke obi ọdịda, abụọ na nke atọ nkebi enwe a-adịghị ala ala, ọrịa infarction n'afọ iri na ụma nke supraventricular tachycardia, nakwa dị ka atrial arrhythmias.

Ọ nwere ike na-ejere ọgwụ na-adịghị mma mmetụta na ahu. N'ọnọdụ ka ukwuu, ha ime na ovadozu, ngwa ngwa igba ogwu n'akwara ochichi, nakwa dị ka ụba uche nke onye ọrịa ahụ iji glycosides. Puru gbasara obi arrhythmias na myocardial conduction. Ọ dịkwa ike afọ ọsịsa, vomiting na ọgbụgbọ, na karịsịa siri ike pathologies - mesenteric infarction. Malfunction nke uche akụkụ na Central ụjọ usoro nwere ike ịkpata ọdịdị isi ọwụwa, ịda mbà n'obi, ịmụ anya arọ nrọ, psychosis, ehighi ura na visual impairment. Mgbe ụfọdụ, ndị ikom pụrụ ịzụlite gynecomastia. E nwekwara puru nke nfụkasị Jeremaya.

Drug "Strofantin" ntuziaka maka ojiji nke dọrọ aka ná ntị banyere contraindications na-adịghị gosiri maka myocardial infarction, na nnukwu ụdị, glycoside igbu egbu, ventricular tachycardia, akpọ bradycardia, hypercalcemia, na hypokalemia, na-arịa ọrịa imi syndrome, ihe aneurysm nke thoracic aorta, atrioventricular ngọngọ abụọ na nke atọ ruo n'ókè.